Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA)

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 1, 2000, Pages 76-80

  Carlsson, ÅsaLinda ^a   Sundkvist, Göran ^a   Groop, Leif ^a   Tuomi, Tiinamaija ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; C PEPTIDE; GLUCAGON; GLUCOSE; INSULIN;

ADULT; AGE; AGED; ARTICLE; AUTOIMMUNE DISEASE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SWEDEN;

ADULT; ARGININE; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCAGON; GLUCOSE; HUMANS; INSULIN; MALE;

EID: 0034457728     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.1.76     Document Type: Article

References (23)

1. Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycemic agents
2. Islet cell antibodies identify latent type 1 diabetes in patients aged 35-75 years at diagnosis
3. Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus
4. Quantitative assay using recombinant human islet glutamic acid decarboxylase .(GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type
5. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease
6. Latent autoimmune diabetes mellitus in adults (LADA): The role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency
7. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis
8. UKPDS 25: Autoantibodies to islet cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
9. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies
10. Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus
11. Metabolic characteristics of autoimmune diabetes mellitus in adults
12. Glutamate decarboxylase antibody levels predict rate of beta-cell decline in adult-onset diabetes
13. Relationship between B-cell function and HLA antigens in patients with type 2 non-insulin-dependent) diabetes
14. β-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients
15. Pancreatic glucagon secretion in normal and diabetic subjects
16. Studies of pancreatic alpha cell function in normal and diabetic subjects
17. Glucagon-insulin relationships
18. Effect of insulin on the exaggerated glucagon response to arginine stimulation in diabetes mellitus
19. Abnormal glucose counter-regulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion
20. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus
21. Potentiation of insulin secretory responses by plasma glucose levels in man: Evidence that hyperglycemia in diabetes compensates for impaired glucose potentiation
22. Combined use of autoantibodies IA-2ab, GADab, IAA, ICA) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop
23. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man